Targeted antisense modulation of inflammatory cytokine receptors

Biotechnology and Bioengineering

Volumn 55, Issue 1, 1997, Pages 72-81

  Roth, C M ^a   Reiken, S R ^a   Le Doux, J M ^a   Rajur, S B ^a   Lu, X M ^a   Morgan, J R ^a   Yarmush, M L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute phase response; Antisense; Gp130; HepG2 cells; IL 6; Receptor targeted delivery

Indexed keywords

ANTIBODIES; CELLS; GENES; MOLECULES; RNA;

ACUTE PHASE RESPONSE; ANTISENSE TECHNOLOGY; CYTOKINES; HAPTOGLOBIN; OLIGONUCLEOTIDES;

PROTEINS;

ANTIBODY; ANTISENSE OLIGODEOXYNUCLEOTIDE; ASIALOGLYCOPROTEIN; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; HAPTOGLOBIN; INTERLEUKIN 6; POLYLYSINE;

ACUTE PHASE RESPONSE; ARTICLE; CELL STRAIN HEPG2; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; RECEPTOR BINDING;

EID: 0031554629     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19970705)55:1<72::AID-BIT9>3.0.CO;2-U     Document Type: Article

References (53)

1. Baumann, H., Gauldie, J. 1994. The acute phase response. Immunol. Today 15: 74-80.
2. Baumann, H., Isseroff, H., Latimer, J. J., Jahreis, G. P. 1988. Phorbol ester modulates interleukin 6- and interleukin 1-regulated expression of acute phase plasma proteins in hepatoma cells. J. Biol. Chem. 263: 17390-17396.
3. Beal, A. L., Cerra, F. B. 1994. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 271: 226-233.
4. Beltinger, C., Saragova, H. U., Smith, R. M., Le Sauteur, L., Shah, N., De Dionisio, L., Christensen, L., Raible, A., Jarett, L., Gewirtz, A. M. 1995. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95: 1814-1823.
5. bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure. Nucl. Acids Res. 22: 2150-2154.
6. Boe, A., Canosi, U., Donini, S., Mastrangeli, R., Ythier, A., Crescenzi, O.S. 1994. Determination of haptoglobin expression in IL-6 treated HepG2 cells by ELISA and by RNA hybridization - evaluation of a quantitative method to measure IL-6. J. Immunol. Meth. 171: 157-167.
7. Brown, D. A., Kang, S.-H., Gryaznov, S. M., DeDionisio, L., Heidenreich, O., Sullivan, S., Xu, X., Nerenberg, M. I. 1994. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269: 26801-26805.
8. Bunnell, B. A., Askari, F. A., Wilson, J. M. 1992. Targeted delivery of antisense oligonucleotides by molecular conjugates. Somat. Cell Molec. Genet. 18: 559-569.
9. Davis, S., Aldrich, T. H., Stahl, N., Pan, L., Taga, T., Kishimoto, T., Ip, N. Y., Yancopolous. G. D. 1993. LIFRβ and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260: 1805-1808.
10. Gerhartz, C., Dittrich, E., Stoyan, T., Rose-John, S., Yasukawa, K., Heinrich, P. C., Graeve, L. 1994. Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gpl30. Eur. J. Biochem. 223: 265-274.
11. Gura, T. 1995. Antisense has growing pains. Science 270: 575-577.
12. Heidenreich, O., Kang, S.-H., Xu, X., Nerenberg, M. 1995. Application of antisense technology to therapeutics. Molec. Med. Today 1: 128-133.
13. Heinrich, P. C., Castell, J. V., Andus, T. 1990. Interleukin-6 and the acute phase response Biochem. J. 265: 621-636.
14. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., Kishimoto, T. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63: 1149-1157.
15. Hirota, H., Yoshida, K., Kishimoto, T., Taga, T. 1995. Continuous activation of gp130, a signal-transducing reeptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA 92: 4862-4866.
16. Ida, N., Sakurai, S., Hosaka, T., Hosoi, K., Kunitomo, T., Shimazu, T., Maruyama, T., Matsuura, Y., Kohase, M. 1989. Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis. Biochem. Biophys. Res. Commun. 165: 728-734.
17. Keller, E. T., Ershler, W. B. 1995. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells. J. Immunol. 154: 4091-4098.
18. Kelly, J. H., Darlington, G. J. 1989. Modulation of the liver specific phenotype in the human hepatoblastoma line HepG2. In Vitro Cell. Devel. Biol. 25: 217-222.
19. Kishimoto, T., Akka, S., Taga, T. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258: 593-597.
20. Kishimoto, T., Taga, T., Akira, S. 1994. Cytokine signal transduction. Cell 76: 253-262.
21. Kishimoto, T., Akira, S., Narazaki, M., Taga, T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254.
22. Lauffenburger, D. A., Linderman, J. J. 1993. Receptors. Oxford University Press, New York.
23. Le Doux, J. M., Morgan, J. L., Yarmush, M. L. 1995. Antisense technology, pp. 1472-1488. In: J. D. Bronzino (ed.), The biomedical engineering handbook. CRC Press, Boca Raton, FL.
24. Lu, X.-M., Fischman, A. J., Jyawook, S. L., Hendricks, K., Tompkins, R. G., Yarmush, M. L. 1994. Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake. J. Nucl. Med. 35: 269-275.
25. Maier, J. A. M., Voulalas, P., Roeder, D., Maciag, T. 1990. Extension of the life-span of human endothelial cells by an interleukin-1a antisense oligomer. Science 249: 1570-1574.
26. 3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor. Bioconjugate Chem. 5: 612-620.
27. Milligan, J. F., Matteuchi, M. D., Martin, J. C. 1993. Current concepts in antisense drug design. J. Med. Chem. 36: 1923-1937.
28. Miyajima, A., Kitamura, T., Harada, N., Yokota T., Arai, K.I. 1992. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10: 295-331.
29. Moroni, M. C., Willingham, M. C., and Beguinot, L. 1992. EGF-R Antisense RNA Blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. J. Biol. Chem. 267: 2714-2722.
30. Morrone, G., Ciliberto, G., Oliviero, S., Arcone, R., Dente, L., Content, J., Cortese, R. 1988. Recombinant interleukin-6 regulates the transcriptional activation of a set of human acute phase genes. J. Biol. Chem. 263: 12554-12558.
31. Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., Kishimoto, T. 1993. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260: 1808-1810.
32. Murray, J. A. H., Crockett, N. 1992. Antisense techniques: an overview, pp. 1-50. In: J. A. H. Murray (ed.), Antisense RNA and DNA (Modern cell biology, vol. 11). Wiley-Liss, New York.
33. Perez, J. R., Li, Y., Stein, C. A., Majumder, S., van Oorschot, A., Narayanan, R. 1994. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91: 5957-5961.
34. Pietzko, D., Zohlnhofer, D., Graeve, L., Fleischer, D., Stoyan, T., Schooltink, H., Rose-John, S., Heinrich, P. C. 1993. The hepatic interleukin-6 receptor. J. Biol. Chem. 268: 4250-4258.
35. Plank, C., Zatloukal, K., Cotten, M., Mechtler, K., Wagner, E. 1992. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetraantennary galactose ligand. Bioconjugate Chem. 3: 533-539.
36. Pugh-Humphreys, R. G. P., Woo, J., Thomson, A. W. 1991. Cytokines and their receptors as potential therapeutic targets, pp. 357-386. In: A. W. Thompson (ed.) The cytokine handbook. Academic Press, San Diego, CA.
37. Remy, J.-S., Kichler, A., Mordvinov, V., Schuber, F., Behr, J.-P. 1995. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc. Natl. Acad. Sci. USA 92: 1744-1748.
38. Sariola, H., Saarma, M., Sainio, K., Arumae, U., Palgi, J., Vaahtokarl, A., Thesleff, I., Karavanov, A. 1991. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor Science 254: 571-573.
39. Schwab, G., Siegall, C. B., Aarden, L. A., Neckers, L. M., Nordan, R. P. 1991. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood 77: 587-593.
40. Stein, C. A., Cheng, Y.-C. 1993. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261: 1004-1012.
41. Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., Monden, M. 1996. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J. Clin. Invest. 97: 244-249.
42. Udelsman, R., Holbrook, N. J. 1994. Endocrine and molecular responses to surgical stress. Curr. Prob. Surg. 31: 655-720.
43. Uhlmann, E., Peyman, A. 1990. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90: 543-584.
44. Wadhwa, M. S., Knoell, D. L., Young, A. P., Rice, K. G. 1995. Targeted gene delivery with a low molecular weight glycopeptide carrier. Bioconjugate Chem. 6: 283-291.
45. Wang, S., Lee, R. J., Cauchon, G., Grenstein, D. G., Low, P. S. 1995. Delivery of antisense oligodeoxynucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA 92: 3318-3322.
46. Wegenka, U. M., Buschmann, J., Lütticken, C, Heinrich, P., Horn, F. 1993. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13: 276-288.
47. Wickstrom, E. 1986. Oligodeoxynucleotide stability in subcellular extracts and culture media. J. Biochem. Biophys. Meth. 13: 97-102.
48. Wu, G. Y., Wu, C. H. 1987. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262: 4429-4432.
49. Wu, G. Y., Wu, C. H. 1992. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J. Biol. Chem. 267: 12436-12439.
50. Yakubov, L. A., Deeva, E. A., Zanytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V., Vlassov, V. V. 1989. Mechanism of oligonucleotide uptake of cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA 86: 6454-5458.
51. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., Kishimoto, T. 1988. Cloning and expression of the human interleukin-6 (BSF-2/IFNb 2) receptor. Science 241: 825-828.
52. Zar, J. H. 1984. Biostatistical analysis. 2nd edition. Prentice Hall, Englewood Cliffs, NJ.
53. Zon, G. 1988. Oligonucleotide analogues as potential therapeutic agents. Pharmaceut. Res. 5: 539-549.